Cargando…
Palliative Systemic Therapy Given near the End of Life for Metastatic Non-Small Cell Lung Cancer
Background: The use of chemotherapy near end of life (EOL) for various cancers is increasing and has been shown to be associated with delayed access to palliative care (PC) and increased aggressiveness in EOL care, without any benefit on survival. Methods: This retrospective study included 90 patien...
Autores principales: | Beaudet, Marc-Étienne, Lacasse, Yves, Labbé, Catherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947187/ https://www.ncbi.nlm.nih.gov/pubmed/35323312 http://dx.doi.org/10.3390/curroncol29030112 |
Ejemplares similares
-
Palliative radiotherapy near the end of life
por: Wu, Susan Y., et al.
Publicado: (2019) -
LUNG CANCER, PALLIATIVE AND END OF LIFE ISSUES
Publicado: (2022) -
The Realities and Associated Factors of Palliative Chemotherapy Near the End of Life in the Patients Enrolled in Palliative Care Unit
por: Jung, Daeun, et al.
Publicado: (2012) -
Chemotherapy use near the end-of-life in patients with metastatic breast cancer
por: Edman Kessler, Luisa, et al.
Publicado: (2020) -
Utilization of palliative radiotherapy for bone metastases near end of life in a population-based cohort
por: Tiwana, Manpreet S., et al.
Publicado: (2016)